title: Treatment of urinary retention caused by uterine leiomyoma with a gonadotropin-releasing hormone agonist:  case report and review.
abstract: METHODS
  We present a case of a symptomatic uterine leiomyoma presenting with recurrent urinary retention that was conservatively managed with a gonadotropin-releasing hormone agonist. As far as we know, this is the first reported case of a successful treatment by gonadotropin-releasing hormone agonist. We also compare other approaches to treatment of urinary retention secondary to uterine leiomyoma found in literature.
  
  
  CONCLUSIONS
  Gonadotropin-releasing hormone agonists can be offered to the patient as a potential, successful nonsurgical option in select cases.
authors: St Luke's Roosevelt Hospital Center, New York, NY, USA. cchu@chpnet.org
authors: Christine M
authors: CM
authors: Chu
authors: Lisa
authors: L
authors: Dabney
authors: Anne
authors: A
authors: Hardart
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D007889:Leiomyoma / Q000150:complications*; D016729:Leuprolide / Q000627:therapeutic use; D008875:Middle Aged; D016055:Urinary Retention / Q000188:drug therapy* / Q000209:etiology; D014594:Uterine Neoplasms / Q000150:complications*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide